1. EP437 HEMATOMA PREVENTION BY TACHOSIL (FIBRIN SEALANT) PATCH IN A HIGH RISK OF POCKET HEMATOMA FORMATION PATIENT WHO IS TAKING WARFARIN ON PACEMAKER INSERTION.
- Author
-
Young Cheon Na, Eun Suk Heo, Hye Mi Lee, and Se Oul Lee
- Subjects
WARFARIN ,FIBRIN tissue adhesive ,HEMATOMA ,CONFERENCES & conventions ,TREATMENT effectiveness ,SURGICAL site ,CARDIAC pacemakers ,DISEASE risk factors - Abstract
Aim: Patients requiring CIED (PM, ICD, CRT) implantation are taking the oral anticoagulant warfarin for different indications such as valve replacement, atrial fibrillation or high risk of embolic stroke. Anticoagulation therapy expose a patient to pocket hematoma formation, which is associated with infection. In this study, we applied tachosil patch in the pacemaker implantation pocket, without interrupting warfarin medication, to investigate prevention of pocket hematoma. Method: 0 Years old, male patient arrived in ER, by syncope. He was high risk of pocket hematoma formation patient with A. fib, Heart failure, Aortic valve and Mitral Valve replacement surgery, high INR and warfarin medication history. During pacemaker insertion by cardiologist, half piece of tachosil patch was inserted to pocket. After that, Generator was inserted on the tachosil patch. And Half piece of tachosil patch was inserted on the generator again. The wound was closed in layers, and a sterile pressure dressing was applied. (Figure 1-4) Results / Discussion: He was discharge postoperative day 5, without any complication. Stitch-out was done at postoperative day 10 and the wound was clean, without interrupting warfarin medication. Conclusion: Tachosil was used as a topical hemostat in surgical filed. But it has not been used on CIED procedure. We used it first, to prevent pocket hematoma formation on pacemaker insertion. Tachosil could be a one way to reduce pocket hematoma formation, in patient at the high risk of thromboembolism, who can't interrupt oral anticoagulant warfarin therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2023